| __timestamp | BioCryst Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 22223073 |
| Thursday, January 1, 2015 | 72758000 | 6966842 |
| Friday, January 1, 2016 | 61008000 | 9000499 |
| Sunday, January 1, 2017 | 66962000 | 13741186 |
| Monday, January 1, 2018 | 84888000 | 19040000 |
| Tuesday, January 1, 2019 | 107068000 | 23559000 |
| Wednesday, January 1, 2020 | 122964000 | 31931000 |
| Friday, January 1, 2021 | 208808000 | 44981000 |
| Saturday, January 1, 2022 | 253297000 | 54234000 |
| Sunday, January 1, 2023 | 216566000 | 63806000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting yet intriguing R&D trajectories.
BioCryst has consistently ramped up its R&D spending, peaking in 2022 with a 390% increase from 2014. This surge underscores their commitment to pioneering treatments, particularly in rare diseases. However, a slight dip in 2023 suggests a strategic recalibration.
Viking, on the other hand, has shown a steady growth in R&D investments, with a remarkable 187% increase from 2014 to 2023. This growth reflects their focus on metabolic and endocrine disorders, positioning them as a rising star in the biotech arena.
Both companies exemplify the dynamic nature of biotech innovation, where strategic R&D investments pave the way for groundbreaking therapies.
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: GSK plc vs Viking Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Viking Therapeutics, Inc.
argenx SE or Viking Therapeutics, Inc.: Who Invests More in Innovation?
Incyte Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Opthea Limited and BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Mesoblast Limited vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds